Published By : 01 Nov 2016 | Published By : QYRESEARCH
Regenerative medicine, on paper, is supposed to be the answer to the modern healthcare dilemma. With the extensively increasing number of patients demanding greater levels of treatment, conventional medicine is unable to keep up with the accelerated increase of the geriatric demographic. The elderly currently form the bulk of all expenses in the healthcare sector and are commonly known to suffer from problems of bone and tissue. Regenerative medicine comes with the potential of completely restoring organs and tissues to their former, healthier selves and have become a beacon of hope for those who cannot find treatment in conventional medicine. The science behind regenerative medicine is not new however, as it has already been decades since the first solid-organ transplants and bone marrow transplants had been carried out. But the rate of advancements in this field are pulling fresh air into the market and opening new avenues of use.
The overall field of regenerative medicine focuses on three aspects: rejuvenation, replacement, and regeneration. The former implies amplifying the human body’s power to heal itself. Replacement is one of the older sciences in regenerative medicine which involves replacing damaged tissue and organs by new ones. Regeneration involves restoration of diseased tissue through proximity of specific tissue or cell types, such as in bone marrow transplants.
In the vast medical research area of bone and joint disorders lie an equally high percentage of the elderly. Their demand for better treatment options is what drives the global market for regenerative medicine. Biomaterials have so far been the best option available in regenerative medicine for most patients. It has enjoyed a rather high success rate for a field that is developing so rapidly. Another field that is growing at lightning speeds due to its sheer area of applications is tissue engineering. Although at a highly nascent stage, development in this field could be just the thing that the healthcare sector is looking for to get a head start on realizing the full potential of regenerative medicine. There are still problems that hinder the development of regenerative medicine, such as a high rate of implant-based infections and the trouble mitigating the chances of tissue rejection. It still bodes well for the market as a whole, as development rates at high and players are optimistic.